
BELMONTE MARIA
Pubblicazioni
Ferrario, F., Franzese, C., Faccenda, V., Vukcaj, S., Belmonte, M., Lucchini, R., et al. (2024). Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 44 [10.1016/j.ctro.2023.100704]. Dettaglio
Colciago, R., Chissotti, C., Ferrario, F., Belmonte, M., Purrello, G., Faccenda, V., et al. (2024). Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer. CURRENT ONCOLOGY, 31(11), 6840-6852 [10.3390/curroncol31110505]. Dettaglio
Bordigoni, B., Trivellato, S., Pellegrini, R., Meregalli, S., Bonetto, E., Belmonte, M., et al. (2024). Automated segmentation in pelvic radiotherapy: A comprehensive evaluation of ATLAS-, machine learning-, and deep learning-based models. PHYSICA MEDICA, 125(September 2024) [10.1016/j.ejmp.2024.104486]. Dettaglio
Bianchi, S., Faccenda, V., Pacifico, P., Parma, G., Saufi, S., Ferrario, F., et al. (2024). Short-term pain control after palliative radiotherapy for uncomplicated bone metastases: a prospective cohort study. MEDICAL ONCOLOGY, 41(1) [10.1007/s12032-023-02238-9]. Dettaglio
Arcangeli, S., Chissotti, C., Ferrario, F., Lucchini, R., Belmonte, M., Purrello, G., et al. (2024). Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a Prospective Study. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 120(5), 1394-1403 [10.1016/j.ijrobp.2024.06.030]. Dettaglio